Fidelity Investments
LPCN icon

Fidelity Investments’s Lipocine LPCN Stock Holding History

Fidelity Investments’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-626
Closed -$5K – 5660
2026
Q1 		$5K Buy
626
+549
+713% +$4.78K ﹤0.01% 4916
2025
Q4 		$618 Buy
77
+18
+31% +$61 ﹤0.01% 5138
2025
Q3 		$169 Buy
+59
New +$179 ﹤0.01% 5166
2025
Q2 		– Sell
-237
Closed -$754 – 5424
2025
Q1 		$754 Buy
237
+172
+265% +$666 ﹤0.01% 4985
2024
Q4 		$317 Buy
+65
New +$330 ﹤0.01% 5028
2024
Q1 		– Sell
-90
Closed -$248 – 5572
2023
Q4 		$248 Buy
90
+31
+53% +$82 ﹤0.01% 4867
2023
Q3 		$173 Buy
59
+50
+556% +$210 ﹤0.01% 4803
2023
Q2 		$45 Buy
+9
New +$42 ﹤0.01% 5034
2022
Q3 		– Sell
-6
Closed – – 5198
2022
Q2 		$0 Sell
6
-2
-25% -$31 ﹤0.01% 5256
2022
Q1 		$0 Sell
8
-3
-27% -$63 ﹤0.01% 5269
2021
Q4 		$0 Hold
11
– – ﹤0.01% 4701
2021
Q3 		$0 Buy
+11
New +$243 ﹤0.01% 4744
2021
Q2 		– Hold
0
– – – 4614

Other funds holding LPCN

SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Fidelity Investments's LPCN Position: Q2 2026 in Review

Fidelity Investments sold out of Lipocine (LPCN) in Q2 2026, closing a stake of 626 shares — an estimated $5K sold.

Fidelity Investments first reported a position in LPCN in Q3 2021 and held it in 12 quarters. The position peaked at $5K in Q1 2026. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

  • Fidelity Investments reported no remaining Lipocine position as of Q2 2026 after selling out during the quarter.
  • Fidelity Investments sold 626 Lipocine shares in Q2 2026, an estimated $5K.
  • Fidelity Investments first reported a position in Lipocine in Q3 2021 and held it in 12 quarters.
  • Fidelity Investments's Lipocine position peaked at $5K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.